Xtacy Therapeutics Corp.
Xtacy Therapeutics Corp.
Indice CSE:
Devise:
Xtacy Therapeutics Corp is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The present focus of the company is in hemp and CBD-related, psilocybin and functional mushrooms, and health-care related industries.
Xtacy Therapeutics Corp. (XTCY)
SEDAR Information
Information d'entreprise
Addresse
1100 - 1111 Melville St
Vancouver, BC V3E 3V6
CanadaTéléphone
6042836110Courriel
[email protected]URL
https://xtacytherapeutics.com/Date d’inscription à la cote
Jeudi, juillet 16, 2009
Agent de transfert
Computershare Investor Services Inc.Relations avec les investisseurs
604-245-5974Courriel
[email protected]Vérificateur
SHIM & Associates LLPCapitalisation
Capitalisation:
54576471Réservé à l'émission:
3353890Company Officers
Meris Kott, Director, CEO
Mark Ireton, Director
Lindsey Perry Jr., Director and CFO
Ashleigh Vogstad, Director
Communiqués de presse
05/12/2023
XTACY Therapeutics Expands MDMA Platform
Bulletins
25/09/2023
2023-0929 - Changement de Nom et de Symbole - Global Wellness Strategies Inc. (GWS)
le 25 septembre/September 2023
Global Wellness Strategies Inc. (GWS) has announced a name and symbol change to Xtacy Therapeutics Corp. (XTCY)
Shares will begin trading under the new name and symbol and with a new CUSIP number on September 26, 2023.
Disclosure documents are available at www.thecse.com.
